Genetic characterization of bone and soft tissue tumors

Acta Orthopaedica Scandinavica, Supplement

Volumn 75, Issue 311, 2004, Pages 21-28

  Mandahl, N ^a   Mertens, F ^a   Panagopoulos, I ^a   Knuutila, S ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMPLICON; ARTICLE; BONE TUMOR; CANCER DIAGNOSIS; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME BANDING PATTERN; CHROMOSOME TRANSLOCATION; COMPARATIVE GENOMIC HYBRIDIZATION; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE TRANSLOCATION; GENETIC ANALYSIS; GENETIC TRAIT; GENETIC VARIABILITY; HUMAN; KARYOTYPE; MOLECULAR GENETICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOFT TISSUE TUMOR;

ARTIFICIAL GENE FUSION; BONE NEOPLASMS; CHONDROSARCOMA; CHROMOSOME ABERRATIONS; GENE REARRANGEMENT; HUMANS; SOFT TISSUE NEOPLASMS; TRANSLOCATION, GENETIC;

EID: 2342595789     PISSN: 03008827     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Åman P, Panagopoulos I, Lassen C, Fioretos T, Mencinger M, Toresson H, Höglund M, Forster A, Rabbitts TH, Ron D, Mandahl N, Mitelman F. Expression patterns of the human sarcoma-associated genes FUS and EWS and the genomic structure of FUS. Genomics 1996; 37: 1-8.
2. Åman P. Fusion genes in solid tumors. Sem Cancer Biol 1999; 9: 303-18.
3. Antonescu CR, Tschernyavsky SJ, Decuseara R, Leung DH, Woodruff JM, Brennan MF, Bridge JA, Neff JR, Goldblum JR, Ladanyi M. Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: A molecular and clinicopathologic study of 82 cases. Clin Cancer Res 2001; 7: 3977-87.
4. Dahlén A, Mertens F, Rydholm A, Brosjö O, Wejde J, Mandahl N, Panagopoulos I. Fusion, disruption and expression of HMGA2 in bone and soft tissue chondromas. Mod Pathol 2003; 16: 1132-40.
5. de Alava E, Kawai A, Healey JH, Fligman I, Meyers PA, Huvos AG, Gerald WL, Jhanwar SC, Argani P, Antonescu CR, Pardo-Mindan FJ, Ginsberg J, Womer R, Lawlor ER, Wunder J, Andrulis I, Sorensen PHB, Ladanyi M. EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. J Clin Oncol 1998; 16: 1248-55.
6. Fletcher CDM, Unni KK, Mertens F (eds.): World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, IARC Press, 2002.
7. Gisselsson D, Höglund M, Mertens F, Johansson B, Dal Cin P, Van den Berghe H, Earnshaw WC, Mitelman F, Mandahl N. The structure and dynamics of ring chromosomes in human neoplastic and non-neoplastic cells. Hum Genet 1999; 104: 315-25.
8. Gisselsson D, Pettersson L, Höglund M, Heidenblad M, Gorunova L, Wiegant J, Mertens F, Dal Cin P, Mitelman F, Mandahl N. Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity. Proc Natl Acad Sci (USA) 2000; 97: 5357-62.
9. Hattinger CM, Rumpler S, Strehl S, Ambros IM, Zoubek A, Pötschger U, Gadner H, Ambros PF. Prognostic impact of deletions at 1p36 and numerical aberrations in Ewing tumors. Genes Chromosomes Cancer 1999; 24: 243-54.
10. Knuutila S. Cytogenetics and molecular pathology in cancer diagnostics. Ann Med 2004; in press.
11. Ladanyi M, Antonescu CR, Leung DH, Woodruff JM, Kawai A, Healey JH, Brennan MF, Bridge JA, Neff JR, Barr FG, Goldsmith JD, Brooks JSJ, Goldblum JR, Ali SZ, Shipley J, Cooper CS, Fisher C, Skytting B, Larsson O. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: A multi-institutional retrospective study of 243 patients. Cancer Res 2002; 62: 135-40.
12. Lin PP, Brody RI, Hamelin AC, Bradner JE, Healey JH, Ladanyi M. Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma. Cancer Res 1999; 59: 1428-32.
13. Mandahl N, Gustafson P, Mertens F, Akerman M, Baldetorp B, Gisselsson D, Knuutila S, Bauer HCF, Larsson O. Cytogenetic aberrations and their prognostic impact in chondrosarcoma. Genes Chromosomes Cancer 2002; 33: 188-200.
14. Mertens F, Strömberg U, Mandahl N, Dal Cin P, De Wever I, Fletcher CDM, Mitelman F, Rosai J, Rydholm A, Sciot R, Tallini G, Van den Bergbe H, Vanni R, Willén H. Prognostically important chromosomal aberrations in soft tissue sarcomas: A report of the Chromosomes and Morphology (CHAMP) Study Group. Cancer Res 2002; 62: 3980-4.
15. Meza-Zepeda LA, Berner J-M, Henriksen J, South AP, Pedeutour F, Dahlberg AB, Godager LH, Nizetic D, Forus A, Myklebost O. Ectopic sequences from truncated HMGIC in liposarcomas are derived from various amplified chromosomal regions. Genes Chromosomes Cancer 2001; 31: 264-73.
16. Mitelman Database of Chromosome Aberrations in Cancer, 2003. Mitelman F, Johansson B, Mertens F (eds.). http: //cgap.nci.nih.gov/Chromosomes/Mitelman
17. Örndal C, Mandahl N, Rydholm A, Willén H, Brosjö O, Heim S, Mitelman F. Supernumerary ring chromosomes in five bone and soft tissue tumors of low or borderline malignancy. Cancer Genet Cytogenet 1992; 60: 170-5.
18. Panagopoulos I, Lassen C, Isaksson M, Mitelman F, Mandahl N, Åman P. Characteristic sequence motifs at the breakpoints of the hybrid genes FUS/CHOP, EWS/CHOP and FUS/ERG in myxoid liposarcoma and acute myeloid leukemia. Oncogene 1997; 15: 1357-62.
19. Panagopoulos I, Mertens F, Isaksson M, Mandahl N. A novel FUS/CHOP chimera in myxoid liposarcoma. Biochem Biophys Res Commun 2000; 279: 838-45.
20. Panagopoulos I, Mertens F, Isaksson M, Limon J, Gustafson P, Skytting B, Akerman M, Sciot R, Dal Cin P, Samson I, Iliszko M, Ryoe J, Dêbiec-Rychter M, Szadowska A, Brosjö O, Larsson O, Rydholm A, Mandahl N. Clinical impact of molecular and cytogenetic findings in synovial sarcoma. Genes Chromosomes Cancer 2001; 31: 362-72.
21. Panagopoulos I, Mertens F, Isaksson M, Domanski HA, Brosjö O, Heim S, Bjerkehagen B, Sciot R, Dal Cin P, Fletcher JA, Fletcher CDM, Mandahl N. Molecular genetic characterization of the EWS/CHN and RBP56/ CHN fusion genes in extraskeletal myxoid chondrosarcoma. Genes Chromosomes Cancer 2002a; 35: 340-52.
22. Panagopoulos I, Mertens F, Debiec-Rychter M, Isaksson M, Limon J, Kardas I, Domanski HA, Sciot R, Perek D, Crnalic S, Larsson O, Mandahl N. Molecular genetic characterization of the EWS/ATF1 fusion gene in clear cell sarcoma of tendons and aponeuroses. Int J Cancer 2002b; 99: 560-7.
23. Panagopoulos I, Storlazzi CT, Fletcher CDM, Fletcher JA, Nascimento A, Domanski HA, Wejde J, Brosjö O, Rydholm A, Isaksson M, Mandahl N, Mertens F. The chimeric FUS/BBF2H7 gene is specific for low grade fibromyxoid sarcoma. Genes Chromosomes Cancer 2004; in press.
24. Pedeutour F, Forus A, Coindre J-M, Berner J-M, Nicolo G, Michiels J-F, Terrier P, Ranchere-Vince D, Collin F, Myklebost O, Turc-Carel C. Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors. Genes Chromosomes Cancer 1999; 24: 30-41.
25. Petit MMR, Schoenmakers EFPM, Huysmans C, Geurts JMW, Mandahl N, Van de Ven WJM. LPP, the preferred fusion partner gene of HMGIC in lipomas, is a novel member of the LIM protein gene familiy. Genomics 1996; 36: 118-29.
26. Rogalla P, Lemke I, Kazmierczak B, Bullerdiek J. An identical HMGIC-LPP fusion transcript is consistently expressed in pulmonary chondroid hamartomas with t(3;12)(q27-28;q14-15). Genes Chromosomes Cancer 2000; 29: 363-6.
27. Sirvent N, Maire G, Pedeutour F. Genetics of dermatofibrosarcoma protuberans family of tumors: From ring chromosomes to tyrosine kinase inhibitor treatment. Genes Chromosomes Cancer 2003; 37: 1-19.
28. Sorensen PH, Lynch JC, Qualman SJ, Tirabosco R, Lim JF, Maure HM, Bridge JA, Crist WM, Triche TJ, Barr FG. PAX3-FKHR and PAX7-FKHR gene fusion are prognostic indicators in alveolar rhabdomyosarcoma: A report from the children's oncology group. J Clin Oncol 2002; 20: 2672-79.
29. Szymanska J, Mandahl N, Mertens F, Tarkkanen M, Karaharju E, Knuutila S. Ring chromosomes in parosteal osteosarcoma contain sequences from 12q13-15: A combined cytogenetic and comparative genomic hybridization study. Genes Chromosomes Cancer 1996; 16: 31-4.
30. Tarkkanen M, Knuutila S. The diagnostic use of cytogenetic and molecular genetic techniques in the assessment of small round cell tumours. Current Diagn Pathol 2002; 8: 338-48.